AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr |
What is the latest Revenue of AARTI DRUGS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,529 Cr |
| Mar2024 | ₹2,716 Cr |
| Mar2023 | ₹2,489 Cr |
| Mar2022 | ₹2,155 Cr |
| Mar2021 | ₹1,806 Cr |
How is Revenue of AARTI DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,529 Cr | -6.90 | |
| Mar2024 | ₹2,716 Cr | 9.14 | |
| Mar2023 | ₹2,489 Cr | 15.49 | |
| Mar2022 | ₹2,155 Cr | 19.31 | |
| Mar2021 | ₹1,806 Cr | - | |
Compare Revenue of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,416.9 Cr | -0.3% | -0.7% | -5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -0.3% |
-0.7% |
-5.6% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses